查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402029

代孕市場至2030年的預測：按類型、年齡層、技術、最終用戶和地區分類的全球分析

Surrogacy Market Forecasts to 2030 - Global Analysis By Type, Age Group, Technology, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC的資料，2023年全球代孕市場規模為2.1034億美元，預計到2030年將達到3.6282億美元，預測期內年複合成長率為8.1%。

在稱為代孕的生殖醫學中，代理孕母代替別人或一對夫婦生孩子。當由於健康狀況而難以或不可能正常懷孕時，可以使用這種輔助生殖技術。代孕主要有兩種型態：妊娠代孕，即代孕母親透過體外受精（IVF）以受精的胚胎代孕；傳統代孕，即代孕母親提供卵子。

根據世界衛生組織（WHO）的報告，開發中國家有四分之一的夫婦患有不孕症。此外，全世界每年有 6,000 至 8,000 萬對夫婦遭受不孕不育的困擾，光是印度就有 1,500 至 2,000 萬對夫婦（25%）遭受不孕的困擾。

意識提升和接受度

社會對不孕症問題的認知提高和公開對話已導致代孕被視為合法且富有同情心的生殖選擇。此外，倡導團體、網路論壇和教育計畫幫助消除圍繞代孕的汙名，並為與不孕症抗爭的單身和夫婦創造更鼓勵性的氛圍。

代理人的數量是有限的。

由於缺乏願意且合適的代孕媽媽，代孕市場受到嚴重限制。難以找到符合醫療和心理要求的合適候選人可能會延遲匹配有意願的父母和代孕媽媽的過程。此外，社會汙名、對潛在健康風險的擔憂以及代孕程序的嚴格性也可能導致這種短缺。

生殖醫學的技術進步

由於生殖醫學技術的不斷進步，包括基因檢測、胚胎篩檢和人工生殖技術的進步，代孕市場存在著巨大的機會。此外，成功率的提高，胚胎選擇的改進以及更先進的生育治療的開發使得代孕成為尋求代孕的父母更可行且更具成本效益的選擇。

監管變化和法律不確定性

不同司法管轄區關於代孕的不同法律體制為代孕產業帶來了嚴重風險。此外，法律的快速變化和法律的模糊性給代孕組織、有意為人父母者和代孕媽媽帶來了困難，並可能導致法律衝突和併發症，阻礙代孕協議的有序進展。

COVID-19 的影響：

COVID-19大流行對代孕市場產生了重大影響，為輔助生殖技術領域帶來了困難和破壞。大流行帶來的旅行限制和關閉阻礙了參與代孕過程的意向父母、代孕媽媽和醫療保健提供者的國際流動。持續的健康問題、診所關閉和生育治療的延誤導致代孕手術暫時減少。此外，大流行的經濟影響可能會影響父母接受代孕服務的能力。

妊娠代孕產業預計將在預測期內成為最大的產業

作為輔助生殖技術中最常見和首選的方法，妊娠代孕佔據了最大的市場佔有率。在懷孕代孕中，卵子和精子由捐贈者或預期父母提供，胚胎是透過體外受精（IVF）產生的。這種方法透過切斷代孕媽媽和孩子之間的遺傳聯繫，提供了更多的情感和法律清晰度。此外，生殖技術的進步使妊娠代孕廣泛認為是一個更可控和可預測的過程。

預計不孕症診所領域在預測期內將出現最高的年複合成長率。

在代孕市場中，年複合成長率最高的細分市場是生育診所。這些專業診所提供最先進的生殖服務，對於解決日益增加的不孕症發病率非常重要。生育診所提供全面的診斷評估，最先進的輔助生殖技術（ART）（包括體外受精（IVF））以及根據每位患者和夫婦的需求量身定做的個人化治療方案。此外，社會對輔助生殖技術的接受度不斷提高，人們對不孕症問題的認知不斷提高，對生育診所提供的服務的需求也隨之增加。

佔有率最大的地區

北美佔據全球代孕市場的最大佔有率。該地區（包括美國和加拿大）由於先進的醫療保健系統、高意識和對生殖技術的大量投資而佔據主導地位。不孕症服務的高需求部分是由於文化上對輔助生殖技術（ART）的接受度以及不孕問題的普遍存在。此外，由於主要生育診所、研究機構和技術開發的集中，北美作為生殖醫療產業主要參與者的地位進一步得到加強。

年複合成長率最高的地區：

在全球代孕市場中，亞太地區的年複合成長率最高。不孕症盛行率上升以及人們對輔助生殖技術（ART）的理解和接受程度不斷提高，推動了亞太地區對生殖健康服務的需求。該地區的快速成長歸因於多種因素，包括生活方式的演變、計劃生育的延遲以及生殖健康的改善。此外，亞太國家不孕症治療的擴大和醫療基礎設施的改善支持市場成長。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球代孕市場：依類型

  • 妊娠代孕
  • 傳統代孕
  • 其他類型

第6章 全球代孕市場：依年齡段

  • 35歲以下
  • 35-37歲
  • 38-39歲
  • 40-42歲
  • 43-44歲
  • 44歲以上

第7章 全球代孕市場：依技術分類

  • 子宮內人工授精（IUI）
  • 體外受精（IVF）
    • 經典/標準 IVF
    • 胞漿內單一精子注射（ICSI）
  • 其他技術

第8章 全球代孕市場：依最終用戶分類

  • 醫院
  • 不孕不育診所
  • 其他最終用戶

第9章 全球代孕市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Extraordinary Conceptions
  • Boston IVF
  • Growing Generations LLC
  • IVIRMA Global
  • Max Healthcare
  • New Hope Fertility Center
  • Bourn Hall International
  • Houston Fertility Center
  • Circle Surrogacy & Egg Donation
  • Nova Ivi Fertility
  • Ovation Fertility
  • Scanfert Clinic
  • Care Fertility Group
Product Code: SMRC24549

According to Stratistics MRC, the Global Surrogacy Market is accounted for $210.34 million in 2023 and is expected to reach $362.82 million by 2030 growing at a CAGR of 8.1% during the forecast period. A surrogate woman bears and gives birth to a child on behalf of another person or couple in a reproductive arrangement known as surrogacy. When conventional conception is difficult or impossible due to medical conditions, this assisted reproductive technology is used. Moreover, the two main forms of surrogacy are gestational surrogacy, in which the surrogate carries an embryo fertilized by in vitro fertilization (IVF), usually using the genetic material of the intended parents or donors, and traditional surrogacy, in which the surrogate contributes her egg.

According to a report by the World Health Organization (WHO), one in four couples in developing nation's experiences infertility. Additionally, 60-80 million couples worldwide suffer from infertility each year, with 15-20 million (25%) residing in India alone.

Market Dynamics:

Driver:

Raising awareness and acceptance

Growing awareness campaigns and a more candid conversation about fertility issues in society are supporting surrogacy's growing acceptance as a legal and compassionate reproductive option. Additionally, advocacy groups, internet forums, and educational programs help dispel the stigmas surrounding surrogacy and create a more encouraging atmosphere for single people and couples dealing with infertility.

Restraint:

Limited number of surrogates available

The surrogacy market is significantly constrained by the lack of willing and suitable surrogates. The process of matching intended parents with surrogates can be delayed when appropriate candidates who fulfill both medical and psychological requirements are difficult to find. Furthermore, social stigmas, worries about potential health hazards, or the rigorous requirements of the surrogacy procedure could all contribute to this shortage.

Opportunity:

Technological progress in reproductive health

Significant opportunities exist for the surrogacy market as a result of ongoing technological advancements in reproductive medicine, such as advances in genetic testing, embryo screening, and artificial reproductive techniques. Moreover, for intended parents, surrogacy is becoming a more practical and cost-effective option thanks to increased success rates, improved embryo selection, and the development of more advanced fertility treatments.

Threat:

Regulation changes and legal uncertainties

Diverse legal frameworks for surrogacy across different jurisdictions present a serious risk to the surrogacy industry. Additionally, swift alterations in laws or legal ambiguities could pose difficulties for surrogacy organizations, intended parents, and surrogates, resulting in possible legal conflicts and complications that could hinder the orderly advancement of surrogacy agreements.

COVID-19 Impact:

The COVID-19 pandemic has had a major effect on the surrogacy market and brought difficulties and disturbances to the assisted reproductive sector. Travel restrictions and lockdowns brought on by the pandemic have hindered the international mobility of intended parents, surrogates, and healthcare providers participating in the surrogacy process. There has been a brief decrease in surrogacy procedures due to ongoing health concerns, clinic closures, and delays in fertility treatments. Furthermore, the pandemic's effects on the economy could have an impact on intended parents' ability to afford surrogacy services.

The Gestational Surrogacy segment is expected to be the largest during the forecast period

As the most common and favored method of assisted reproduction, gestational surrogacy commands the largest share of the market. When a person is used in a gestational surrogacy, their eggs and sperm from donors or the intended parents are used to create an embryo through in vitro fertilization (IVF). This approach provides more emotional and legal clarity by severing genetic ties between the surrogate and the child. Moreover, reproductive technology advancements have made gestational surrogacy more widely recognized as a more controlled and predictable process.

The Fertility Clinics segment is expected to have the highest CAGR during the forecast period

In the surrogacy market, the segment with the highest CAGR is fertility clinics. These specialist clinics, which provide a range of cutting-edge reproductive services, are essential in tackling the growing incidence of infertility. Fertility clinics offer thorough diagnostic evaluations, state-of-the-art assisted reproductive technologies (ART), including in vitro fertilization (IVF), and individualized treatment programs made to meet each patient's or couple's specific needs. Additionally, the demand for the services provided by fertility clinics has increased due to rising societal acceptance of ART and increased awareness of fertility issues.

Region with largest share:

In the global surrogacy market, North America holds the largest share. Because of its sophisticated healthcare system, high level of awareness, and large investments in reproductive technologies, this region-which includes the United States and Canada-dominates. The high demand for fertility services is partly due to the cultural acceptance of assisted reproductive technologies (ART) and the prevalence of infertility problems. Moreover, North America's status as a major player in the reproductive healthcare industry is further cemented by the region's concentration of top fertility clinics, research institutes, and technological developments in the field.

Region with highest CAGR:

In terms of the global market for surrogacy, the Asia-Pacific region has the highest CAGR. The demand for reproductive services in Asia-Pacific is driven by the rising prevalence of infertility as well as increased understanding and acceptance of assisted reproductive technologies (ART). The region's rapid growth is caused by a number of factors, including evolving lifestyles, postponing family planning, and improvements in reproductive health. Furthermore, expanding fertility treatments and better healthcare infrastructure in Asia-Pacific nations support the market's growth.

Key players in the market:

Some of the key players in Surrogacy market include Extraordinary Conceptions, Boston IVF, Growing Generations LLC, IVIRMA Global, Max Healthcare, New Hope Fertility Center, Bourn Hall International, Houston Fertility Center, Circle Surrogacy & Egg Donation, Nova Ivi Fertility, Ovation Fertility, Scanfert Clinic and Care Fertility Group.

Key Developments:

In November 2023, IVI RMA, one of the largest reproductive medicine groups in the world, has signed a definitive agreement to acquire the North American Operations of Eugin Group, consisting of the Boston IVF fertility network and Toronto-based TRIO, from healthcare group Fresenius. The strategic additions will grow IVI RMA to become a leading fertility group in North America and reinforce the company's commitment to providing evidence-based fertility solutions with the greatest chance of success to the greatest number of patients.

In October 2023, Boston IVF, a renowned leader in fertility research and patient care since its establishment in 1986, is proud to announce its substantial participation in the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo. This prestigious annual event, in New Orleans, Louisiana, from October 14-18, brought together global experts to share groundbreaking advancements in technology, treatments, and patient care in reproductive medicine.

Types Covered:

  • Gestational Surrogacy
  • Traditional Surrogacy
  • Other Types

Age Groups Covered:

  • Below 35 Years
  • 35-37 Years
  • 38-39 Years
  • 40-42 Years
  • 43-44 Years
  • Over 44 Years

Technologies Covered:

  • Intrauterine Insemination (IUI)
  • In-vitro Fertilization (IVF)
  • Other Technologies

End Users Covered:

  • Hospitals
  • Fertility Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Surrogacy Market, By Type

  • 5.1 Introduction
  • 5.2 Gestational Surrogacy
  • 5.3 Traditional Surrogacy
  • 5.4 Other Types

6 Global Surrogacy Market, By Age Group

  • 6.1 Introduction
  • 6.2 Below 35 Years
  • 6.3 35-37 Years
  • 6.4 38-39 Years
  • 6.5 40-42 Years
  • 6.6 43-44 Years
  • 6.7 Over 44 Years

7 Global Surrogacy Market, By Technology

  • 7.1 Introduction
  • 7.2 Intrauterine Insemination (IUI)
  • 7.3 In-vitro Fertilization (IVF)
    • 7.3.1 Classical/Standard IVF
    • 7.3.2 Intracytoplasmic Sperm Injection (ICSI)
  • 7.4 Other Technologies

8 Global Surrogacy Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Fertility Clinics
  • 8.4 Other End Users

9 Global Surrogacy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Extraordinary Conceptions
  • 11.2 Boston IVF
  • 11.3 Growing Generations LLC
  • 11.4 IVIRMA Global
  • 11.5 Max Healthcare
  • 11.6 New Hope Fertility Center
  • 11.7 Bourn Hall International
  • 11.8 Houston Fertility Center
  • 11.9 Circle Surrogacy & Egg Donation
  • 11.10 Nova Ivi Fertility
  • 11.11 Ovation Fertility
  • 11.12 Scanfert Clinic
  • 11.13 Care Fertility Group

List of Tables

  • Table 1 Global Surrogacy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 4 Global Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 5 Global Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 6 Global Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 7 Global Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 8 Global Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 9 Global Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 10 Global Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 11 Global Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 12 Global Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 13 Global Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 14 Global Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 15 Global Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 16 Global Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 17 Global Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 18 Global Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 19 Global Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 20 Global Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 21 Global Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 22 Global Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 25 North America Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 26 North America Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 27 North America Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 28 North America Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 29 North America Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 30 North America Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 31 North America Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 32 North America Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 33 North America Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 34 North America Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 35 North America Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 36 North America Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 37 North America Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 38 North America Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 39 North America Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 40 North America Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 41 North America Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 43 North America Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 44 North America Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 47 Europe Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 48 Europe Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 49 Europe Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 50 Europe Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 51 Europe Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 52 Europe Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 53 Europe Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 54 Europe Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 55 Europe Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 56 Europe Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 57 Europe Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 58 Europe Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 59 Europe Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 60 Europe Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 61 Europe Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 62 Europe Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 63 Europe Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 64 Europe Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 65 Europe Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 66 Europe Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 Asia Pacific Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 69 Asia Pacific Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 70 Asia Pacific Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 71 Asia Pacific Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 72 Asia Pacific Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 73 Asia Pacific Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 74 Asia Pacific Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 75 Asia Pacific Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 76 Asia Pacific Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 77 Asia Pacific Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 78 Asia Pacific Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 79 Asia Pacific Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 80 Asia Pacific Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 81 Asia Pacific Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 82 Asia Pacific Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 83 Asia Pacific Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 84 Asia Pacific Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 85 Asia Pacific Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 86 Asia Pacific Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 87 Asia Pacific Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 88 Asia Pacific Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 South America Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 91 South America Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 92 South America Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 93 South America Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 94 South America Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 95 South America Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 96 South America Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 97 South America Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 98 South America Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 99 South America Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 100 South America Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 101 South America Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 102 South America Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 103 South America Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 104 South America Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 105 South America Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 106 South America Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 107 South America Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 108 South America Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 109 South America Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 110 South America Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 111 Middle East & Africa Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 113 Middle East & Africa Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 114 Middle East & Africa Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 115 Middle East & Africa Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 116 Middle East & Africa Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 117 Middle East & Africa Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 118 Middle East & Africa Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 119 Middle East & Africa Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 120 Middle East & Africa Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 121 Middle East & Africa Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 122 Middle East & Africa Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 123 Middle East & Africa Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 124 Middle East & Africa Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 125 Middle East & Africa Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 126 Middle East & Africa Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 127 Middle East & Africa Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 128 Middle East & Africa Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 129 Middle East & Africa Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 130 Middle East & Africa Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 131 Middle East & Africa Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 132 Middle East & Africa Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)